SNWV SANUWAVE Health Inc

SANUWAVE Health Announces Regulatory Clearance for dermaPACE in Mexico by the Federal Commission for Protection against Sanitary Risks (COFEPRIS)

SANUWAVE Health Announces Regulatory Clearance for dermaPACE in Mexico by the Federal Commission for Protection against Sanitary Risks (COFEPRIS)
EN
14/10/2020

Underlying

SNWVSANUWAVE Health Inc

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on SANUWAVE Health Inc

 PRESS RELEASE
Free
SNWV SANUWAVE Health...

Sanuwave Health to Uplist to the Nasdaq Global Market

Sanuwave Health to Uplist to the Nasdaq Global Market Trading Under the Ticker “SNWV” Expected to Begin on March 7, 2025 EDEN PRAIRIE, Minn., March 04, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the “Company” or "Sanuwave”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, announced today that its common stock has been approved for listing on the Nasdaq Global Market (“Nasdaq”). Trading on Nasdaq is expected to commence at the market open on March 7, 2025, with shares continuing to trade under the ticker symbol “SNWV.” The Company’s shares will...

March 4, 2025 1 EN
 PRESS RELEASE
Free
SNWV SANUWAVE Health...

SANUWAVE Health to Participate in 37th Annual Roth Conference

SANUWAVE Health to Participate in 37th Annual Roth Conference EDEN PRAIRIE, Minn., Feb. 19, 2025 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, today announced that Morgan Frank, Chief Executive Officer, will participate in the 37th Annual Roth Conference to be held on March 16-18 at the Laguna Cliffs Marriott Resort & Spa in Dana Point, California. Management will be available for one-on-one meetings throughout the conference. Interested investors should contact their Roth representative or email to sched...

February 19, 2025 1 EN
 PRESS RELEASE
Free
SNWV SANUWAVE Health...

SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Resu...

SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results Q3 2024 revenues were $9.4 million, up 89% from Q3 2023. This was an all-time quarterly record for the Company. Q3 2024 gross margin was 75.5%, vs 71.5% in Q3 2023 GAAP Operating Income was $2.0 million Company provides guidance for revenue growth of 40-50% for Q4 2024 versus Q4 2023 EDEN PRAIRIE, Minn., Nov. 08, 2024 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (the "Company" or "SANUWAVE”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, is pleased to provide its financial ...

November 8, 2024 1 EN
 PRESS RELEASE
Free
SNWV SANUWAVE Health...

SANUWAVE Will Host a Conference Call on November 8, 2024 at 8:30 AM (E...

SANUWAVE Will Host a Conference Call on November 8, 2024 at 8:30 AM (ET) to Present Q3 Financial Results EDEN PRAIRIE, Minn., Nov. 04, 2024 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (the "Company" or "SANUWAVE”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Friday, November 8, 2024, at 8:30 AM (ET) to present its Q3 2024 financial results. Telephone access to the call will be available by dialing the following numbers: Participant Dial-in Information Toll Free: 1-800-267-6316 Toll/International: 1-203-518-97...

November 4, 2024 1 EN
 PRESS RELEASE
Free
SNWV SANUWAVE Health...

SANUWAVE Announces Reverse Stock Split, Note and Warrant Exchange, and...

SANUWAVE Announces Reverse Stock Split, Note and Warrant Exchange, and PIPE Offering 1-for-375 reverse stock split effective at market open today Exchanged $43.2 million in principal amount of convertible notes and warrants previously exercisable for approximately 1.7 billion pre-split shares for approximately 4.0 million post-split shares Closed $10.3 million equity only PIPE offering at $8.25 per share of common stock led by certain institutional investors, including AWM Investment Company, Inc., the investment adviser of the Special Situations Funds and with participation from Ma...

October 18, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch